newsfilter
← Latest News
PR Newswire·

Revance Stockholders Urged to Tender Their Shares in Support of Crown Transaction by the February 4th Deadline

Crown Laboratories, Inc. ("Crown") and Revance Therapeutics, Inc. (NASDAQ: RVNC) ("Revance"), today reminded Revance stockholders of the...